AbbVie Inc. Stock Falls Wednesday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) shed 0.25% to $159.39 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.59% to 4,027.26 and the Dow Jones Industrial Average rising 0.28% to 34,194.06. The stock's fall snapped a four-day winning streak. AbbVie Inc. closed $16.52 short of its 52-week high ($175.91), which the company achieved on April 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Pfizer Inc. (PFE) fell 0.47% to $48.85, Eli Lilly & Co. (LLY) rose 0.23% to $361.72, and AstraZeneca PLC ADR (AZN.LN) rose 0.18% to $66.12. Trading volume (3.2 M) remained 2.6 million below its 50-day average volume of 5.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 23, 2022.
(END) Dow Jones Newswires
November 23, 2022 16:32 ET (21:32 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.